| Literature DB >> 23839114 |
Tatiana M Souza-Moreira1, Juliana A Severi, Keunsook Lee, Kanya Preechasuth, Emerson Santos, Neil A R Gow, Carol A Munro, Wagner Vilegas, Rosemeire C L R Pietro.
Abstract
In addition to the bio-guided investigation of the antifungal activity of Plinia cauliflora leaves against different Candida species, the major aim of the present study was the search for targets on the fungal cell. The most active antifungal fraction was purified by chromatography and characterized by NMR and mass spectrometry. The antifungal activity was evaluated against five Candida strains according to referenced guidelines. Cytotoxicity against fibroblast cells was determined. The likely targets of Candida albicans cells were assessed through interactions with ergosterol and cell wall composition, porosity and architecture. The chemical major component within the most active antifungal fraction of P. cauliflora leaves identified was the hydrolysable tannin casuarinin. The cytotoxic concentration was higher than the antifungal one. The first indication of plant target on cellular integrity was suggested by the antifungal activity ameliorated when using an osmotic support. The most important target for the tannin fraction studied was suggested by ultrastructural analysis of yeast cell walls revealing a denser mannan outer layer and wall porosity reduced. It is possible to imply that P. cauliflora targeted the C. albicans cell wall inducing some changes in the architecture, notably the outer glycoprotein layer, affecting the cell wall porosity without alteration of the polysaccharide or protein level.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23839114 PMCID: PMC6269720 DOI: 10.3390/molecules18078095
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1(a) Semi-preparative HPLC-UV chromatogram of F2 from P. cauliflora leaves. Chromatographic conditions: HPLC with UV detector set at 254 nm, the column was RP-18, elution phase acidified with trifluoroacetic acid 0.05% in linear gradient elution of CH3OH/H2O (20:80 in 15 min, 20:80→50:50 in 35 min, 50:50→95:5 in 40 min); flow-rate of 2.5 mL/min. (b) Structure of casuarinin. This hydrolysable tannin is a C-glycosidic ellagitannin with an open-chain glucose core called casuarinin.
Antifungal activity and cytotoxicity of P. cauliflora leaf samples, in µg/mL.
|
|
|
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Samples | MIC | MFC | MIC | MFC | MIC | MFC | MIC | MFC | MIC | MFC | CC50 |
| Extract | 156 | 625 | 156 | 156 | 19 | 39 | 78 | 156 | 312 | 1250 | 417 |
| EAF | 625 | 1250 | NT | NT | 19 | 78 | 312 | 625 | 312 | 625 | 221 |
| BF | 78 | 1250 | 156 | 156 | 19 | 39 | 19 | 19 | 156 | 1250 | 767 |
| AF | 312 | >1250 | NT | NT | 39 | 78 | 39 | 78 | 312 | 1250 | 1500 |
| F2 | 78 | 312 | 156 | 312 | 625 | >1250 | 156 | 1250 | 312 | >1250 | >400 |
| casuarinin | 580 | 580 | 580 | >580 | 26 | 580 | 580 | 580 | 145 | 580 | >116 |
| FCZ | 4 | 8 | 2 | 32 | 32 | 32 | 4 | 4 | 32 | 32 | NA |
| Amph B | 0.25 | 0.25 | 1 | 8 | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 2 | NA |
MIC and MFC results are expressed as the mode in µg/mL, after 24 h and 48 h of incubation, respectively. C.a. = C. albicans; C.k. = C. krusei; C.p. = C. parapsilosis; C.t. = C. tropicalis. EAF = ethyl acetate fraction; BF = n-butanolic fraction; AF = aqueous fraction; F2 = fraction 2 from BF; NT = not tested; NA = not applicable. FCZ = fluconazole (64 to 0.06 µg/mL). Amph B = amphotericin B (16 to 0.03 µg/mL). MIC test range concentrations: 1,250 to 2 µg/mL of extract and fractions and 580 to 1 µg/mL of casuarinin. CC50 test range concentrations: 2,000 to 4 µg/mL of extract or fractions and 116 to 0.2 µg/mL of casuarinin. CC50 = 50% cytotoxic concentration. Results are expressed according to the regression calculation in µg/mL.
Ergosterol quantification, in percentage (%).
| SAMPLES |
|
|
|
|
|---|---|---|---|---|
| Control | 1.38 ± 0.32 | 1.13 ± 0.70 | 0.34 ± 0.30 | 1,94 ± 0.10 |
| BF | 2.03 ± 0.77(+48) | 1.44 ± 0.58(+28) | 0.77 ± 0.70(+29) | 1,30 ± 0.86(−33) |
| FCZ | 0.40 ± 0.23(−71) * | 0.68 ± 0.08(−40) | 0.05 ± 0.05(−84) * | 0(−100) * |
Ergosterol content expressed as a percentage (%) of the wet weight of the cell ± standard deviation. In parentheses there is the increased (+) or decreased (−) percentage value relative to the ergosterol content in control. BF = n-butanolic fraction. FCZ = fluconazole. * Statistically significant.
Antifungal activity of the plant preparations in the presence of ergosterol or sorbitol, in µg/mL.
| Ergosterol | Sorbitol | |||||||
|---|---|---|---|---|---|---|---|---|
| Samples |
|
|
|
|
|
|
|
|
| Extract | 5000 | 39 | 312 | 625 | 2500 | 39 | 2500 | 156 |
| EAF | 5000 | 39 | 1250 | 625 | 5000 | 39 | 2500 | 312 |
| BF | 5000 | 39 | 1250 | 312 | 5000 | 39 | 1250 | 312 |
| AF | 5000 | 78 | 2500 | 625 | 5000 | 78 | 2500 | 1250 |
| F2 | 1250 | 78 | 1250 | 312 | 1250 | 78 | 625 | 312 |
| FCZ | NA | NA | NA | NA | 8 | 64 | 4 | 64 |
| Amph B | 2 | 16 | 16 | 4 | 0.25 | 1 | 1 | 1 |
MIC results are expressed as the mode in µg/mL, for 24–48 h. C.a. = C. albicans; C.k. = C. krusei; C.p. = C. parapsilosis; C.t. = C. tropicalis. FCZ = fluconazole (64 to 0.06 µg/mL). Amph B = amphotericin B (16 to 0.03 µg/mL).Test concentrations: 5,000 to 8 µg/mL of extract. EAF = ethyl acetate fraction; BF = n-butanolic fraction; AF = aqueous fraction; F2 = fraction 2 from BF; NA = not applicable.
Figure 2Ultrastructural analysis of the C. albicans yeast cell surface. (a) Transmission electron microscopy of cells without treatment (b) And cells treated with 156 µg/mL of subfraction F2 for 16 h. Magnification of 130,000×.
Cell wall assay results comparing non-treated and casuarinin fraction treated C. albicans SC5314.
| Control cells | Treated cells | |||
|---|---|---|---|---|
| Yeast | Hyphae | Yeast | Hyphae | |
| Chitin (%) | 5.1 ± 1.8 | 21.8 ± 1.3 | 4.2 ± 1.4 | 22.1 ± 4.0 |
| Glucan (%) | 66.3 ± 4.9 | 68.8 ± 0.6 | 73.4 ± 4.0 | 67.3 ± 2.0 |
| Mannan (%) | 28.6 ± 5.6 | 9.4 ± 1.6 | 22.4 ± 5.3 | 10.6 ± 2.1 |
| Covalently attached cell wall protein (µg/mL) | 109.4 ± 5.5 | 90.2 ± 5.0 | 114.5 ± 4.2 | 101.3 ± 2.0 * |
| Non-covalently attached cell wall protein (µg/mL) | 226.5 ± 1.5 | 156.6 ± 0.5 | 227.6 ± 3.4 | 173.3 ± 0.1 |
Results of saccharide content are given as percentage (%) of total dried cell wall, while protein content is given as µg/mL and are the average ± standard deviation of triplicate samples.* Statistically significant.